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Background: Over the last five years, there have been numerous reports of association of juvenile idiopathic
arthritis with single nucleotide polymorphisms (SNPs) at various loci outside the major histocompatibility complex
(MHC) region. However, the majority of these association findings have been generated using a limited number of
international cohorts, and thus there is benefit in further independent replication. To address this, we examined a
total of 56 SNPs in 42 non-MHC gene regions previously reported to be associated with JIA, in the ChiLdhood
Arthritis Risk factor Identification sTudY (CLARITY), a new Australian collection of cases and healthy child controls.
Findings: Genotyping was performed on a total of 324 JIA cases (mean age 9.7 years, 67.3% female) and 568
controls (mean age 7.8 years, 40.7% female). We demonstrated clear evidence for replication of association of JIA
with SNPs in or around c12orf30, c3orf1, PTPN22, STAT4, and TRAF1-C5, confirming the involvement of these loci in
disease risk. Further, we generated evidence supportive of replication of association of JIA with loci containing AFF3,
CD226, MBL2, PSTPIP1, and RANTES (CCL5). These results were robust to sensitivity analyses for ethnicity.
Conclusion: We have provided valuable independent data as to the underlying genetic architecture of this
understudied pediatric autoimmune disease, further confirming five loci outside the MHC, and supporting a role for
a further five loci in determining disease risk.
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Our understanding of the genetic basis of juvenile idio-
pathic arthritis (JIA) has recently increased, but still lags
behind many other autoimmune diseases. This is largely
due to the paucity of DNA collections internationally.
While association of JIA with variation in the major
histocompatibility complex (MHC) is well-established
[1], over the last five years, there have been a number of
reports of new JIA susceptibility loci that lie outside this
region. These findings have resulted from candidate gene
approaches (for example, examining genes known to be
associated with rheumatoid arthritis), and more recently,
from a limited number of genome-wide association study* Correspondence: justine.ellis@mcri.edu.au
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reproduction in any medium, provided the or(GWAS) approaches. The vast majority of reports de-
scribe discovery and replication findings generated from
two large sample collections, from the UK and the US [2].
Thus, although solid evidence for association with JIA has
usually been described, for many of the identified loci, fur-
ther replication in an entirely independent JIA sample
would be beneficial in confirming their contribution to
disease risk.
To address this, we performed a single nucleotide
polymorphism (SNP) replication study within a new
sample of JIA cases and healthy hospital-based child
controls, collected so far as part of the ongoing Austra-
lian CLARITY study (ChiLdhood Arthritis Risk factor
Identification sTudY) [3]. We selected 56 SNPs from 42
gene regions. Candidacy was based on published evi-
dence of association, or a trend towards association, with
total JIA, or one or more of its subtypes. These genes. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.




replication?‡Gene SNP Minor allele Case MAF Control MAF P OR (95% CI)
ADAD1-IL2-IL21 rs17388568 [6] A 0.25 0.24 0.29 R 0.55 1.07 (0.85, 1.36) N
rs13143866 [6] A 0.28 0.26 0.28 D 0.31 1.12 (0.90, 1.40) N
rs6822844 [4,5] T 0.13 0.12 0.42 R 0.46 1.12 (0.83, 1.49) N
AFF3 rs1160542 [5] G 0.49 0.46 0.16 R 0.25 1.12 (0.92, 1.36) P
ANGPT1 rs1010824 [6] T 0.17 0.16 0.71 D 0.82 1.03 (0.79, 1.34) N
ATXN2 rs653178 [7] G 0.55 0.46 0.00023 A 0.00023 1.44 (1.19, 1.76) Y
BACH2 rs11755527 [7] G 0.44 0.46 0.34 D 0.41 0.92 (0.76, 1.12) N
C12orf30 rs17696736 [6,8] G 0.50 0.41 0.00044 T 0.0005 1.42 (1.16, 1.72) Y
C3orf1 rs4688011 [9] A 0.24 0.19 0.016 D 0.02 1.32 (1.04, 1.68) Y
CD14 rs2569190 [11] A 0.48 0.50 0.24 R 0.43 0.92 (0.76, 1.12) N
CD226 rs763361 [5] T 0.52 0.48 0.059 A 0.059 1.21 (0.99, 1.47) P
CLEC16A rs6498169 [12] G 0.37 0.35 0.30 A 0.3 1.11 (0.91, 1.36) N
COG6 rs7993214 [6] T 0.30 0.29 0.41 T 0.41 1.09 (0.88, 1.36) N
CTLA4 rs3087243 [5] A 0.46 0.46 0.80 R 0.97 0.997 (0.82, 1.21) N
DCN1* rs939898 [22] G 0.21 0.18 0.057 D 0.11 1.22 (0.95, 1.56) N
ERAP1† rs30187 [13] T 0.39 0.37 0.36 D 0.46 1.08 (0.88, 1.32) N
FHIT* rs9311745 [22] C 0.07 0.08 0.86 A 0.86 0.97 (0.66, 1.41) N
HUNK* rs2833547 [22] T 0.25 0.26 0.46 D 0.66 0.95 (0.76, 1.19) N
IL15 rs13139573 [9] T 0.47 0.43 0.0016 G 0.13 1.16 (0.96, 1.41) ?
IL23R rs11209026 [13] A 0.07 0.05 0.22 T 0.23 1.29 (0.85, 1.94) N
rs11465804 [6] G 0.06 0.05 0.44 T 0.45 1.18 (0.77, 1.80 N
IL2RA rs12251307 [6] T 0.11 0.12 0.34 A 0.34 0.86 (0.63, 1.17) N
rs706778 [2] A 0.45 0.43 0.26 T 0.26 1.12 (0.92, 1.36) N
rs2104286 [6,14] G 0.21 0.22 0.21 R 0.63 0.94 (0.74, 1.20) N
IL7R rs6897932 [5] T 0.25 0.23 0.17 D 0.19 1.16 (0.93, 1.46) N
JMJD1C-REEP3 rs6479891 [9] T 0.17 0.18 0.44 D 0.64 0.94 (0.73, 1.21) N
rs12411988 [9] C 0.16 0.17 0.47 R 0.74 0.96 (0.73, 1.24) N
KIF5A rs1678542 [15] C 0.36 0.39 0.22 A 0.22 0.88 (0.72, 1.08) N
LPP rs1464510 [7] T 0.46 0.46 0.81 R 0.93 1.01 (0.83, 1.23) N
MBL2 rs1800451 [16] A 0.03 0.02 0.059 T 0.061 1.88 (0.96, 3.67) P
MEFV rs224204 [17] T 0.49 0.47 0.36 D 0.38 1.09 (0.90, 1.33) N
NLRP30 rs3806265 [17] C 0.34 0.35 0.46 D 0.54 0.94 (0.76. 1.15) N
NOD2 rs1861759 [17] C 0.39 0.37 0.26 D 0.64 1.05 (0.86, 1.28) N
NRBF2-EGR2 rs10995450 [9] T 0.24 0.24 0.96 R 0.98 0.998 (0.79, 1.25) N
PRKCQ rs4750316 [15] C 0.17 0.18 0.33 R 0.42 0.90 (0.70, 1.17) N
PSTPIP10 rs4078354 [17] T 0.33 0.36 0.13 A 0.85 (0.69, 1.05) P
PTPN2 rs1893217 [6] C 0.20 0.18 0.50 A 0.5 1.09 (0.85, 1.40) N
rs7234029 [2,6] G 0.19 0.18 0.43 D 0.49 1.09 (0.85, 1.40) N
rs2542151 [6] G 0.20 0.18 0.49 D 0.53 1.08 (0.85, 1.39) N
PTPN22 rs2476601 [6,18] A 0.10 0.07 0.006 A 0.006 1.62 (1.15, 2.30) Y
RANTES (CCL5) rs2107538 [19] T 0.21 0.18 0.039 D 0.097 1.23 (0.96, 1.58) P∞
rs2280788 [19] G 0.02 0.02 0.30 T 0.31 1.45 (0.71, 2.96) N
SLITRK5* rs1074044 [22] C 0.44 0.44 0.81 D 0.9 1.01 (0.83, 1.23) N
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Table 1 Clarity SNP association results, full sample (Continued)
STAT4 rs8179673 [15] C 0.29 0.24 0.012 D 0.024 1.29 (1.03, 1.61) Y
rs3821236 [6] A 0.25 0.21 0.013 D 0.038 1.28 (1.01, 1.61) Y
rs7574865 [6,8,15] T 0.29 0.24 0.0091 D 0.025 1.29 (1.03, 1.61) Y
TNFAIP3 rs6920220 [8,15] A 0.22 0.20 0.29 A 0.29 1.14 (0.90, 1.44) N
rs13207033 [15] A 0.26 0.29 0.26 D 0.29 0.89 (0.71, 1.11) N
TRAF1-C5 rs2900180 [15] T 0.37 0.32 0.014 R 0.046 1.23 (1.00, 1.51) Y
rs3761847 [21] A 0.42 0.40 0.32 A 0.32 1.11 (0.90, 1.36) N
VTCN1 rs12046117 [22] T 0.17 0.15 0.33 A 0.33 1.14 (0.87, 1.49) N
* No gene attribution in original publication, closest gene by UCSC Genome Browser listed.
† Associated specifically with enthesitis related JIA in original report.
0 Associated specifically with psoriatic JIA in original report.
§ Model providing most significant P value: A = allelic, G = genotypic, T = Cochrane Armitage Trend Test (additive), D = dominant, R = recessive.
‡ Evidence for replication Y = Yes, P = Partial, N = No. See text for definitions. ? = potential for A/T allele reversal with respect to the prior report.
∞ Finding listed as P (partially replicated) since for this SNP, prior evidence was for a non-significant trend towards association in a direction consistent with
our own.
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ATXN2 [7], BACH2 [7], c12orf30 [6,8], c3orf1 [9], CCR5
[10], CD14 [11], CD226 [5], CD247 [2], CLEC16A [12],
COG6 [6], CTLA4 [5], ERAP1 [13], IL12A [7], IL15 [9],
IL23R [6,13], IL2RA [2,6,14], IL7R [5], JMJD1C-REEP3
[9], KIF5A [15], LPP [7], MBL2 [16], MEFV [17], NLRP3
[17], NOD2 [17], NRBF2-EGR2 [9], PRKCQ [15],
PSTPIP1 [17], PTPN2[2,6], PTPN22 [6,18], RANTES
(CCL5) [19], STAT4 [6,8,15], TNFA [20], TNFAIP3 [8,15],
TRAF1-C5 [15,21], and VTCN1 [22]. Additional SNPs
from four other loci not attributed to any gene in the
original publication but lying closest to the genes DCN1,
FHIT, HUNK, and SLITRK5 [22] were also selected.




























































































































Figure 1 Forest Plot comparing previously published odds ratios (OR
more than one previously published OR was identified for a SNP, the OR b
excluded from this figure (see text for explanation). For genes with multipl
as listed in Table 1. * No gene attribution in original publication, closest ge(mean age 9.7 years, 67.3% female) and 568 controls
(mean age 7.8 years, 40.7% female) using the Sequenom
MassARRAY system (assay design details available from
the authors). After quality control pruning (removal of
SNPs with Hardy Weinberg Equilibrium p < 0.01, and
SNPs or samples with < 90% genotyping success rate) ge-
notypes were successfully generated for 51 SNPs at 38
gene loci in 318 cases and 556 controls. SNPs excluded
from analysis are listed in Additional file 1. Allelic, geno-
typic, additive (Cochrane-Armitage test for trend), dom-
inant and recessive association analyses were performed
using PLINK v1.07 [23]. Given the a priori evidence for












































































































































































Published OR Published 95% CI
CLARITY OR CLARITY 95% CI
s) with CLARITY ORs for genes examined via nearby SNPs. Where
ased on the largest sample size was used. Some examined genes were
e SNPs (eg ADAD1-IL2-IL21) the SNPs are presented in the same order
ne by UCSC Genome Browser listed.
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cases and controls, including p values for the most highly
significant test and allelic test for all SNPs analysed is
shown in Table 1. Figure 1 shows a forest plot of the allelic
odds ratios generated in the CLARITY sample compared
to previously published odds ratios (ORs) for the majority
of SNPs tested. Some SNPs were not included in this fig-
ure, including SNPs for which an OR was not presented
in the original report, or where SNPs were previously as-
sociated specifically with rarer JIA subtypes. Our data
demonstrates clear evidence of replication (defined as
p < 0.05 for any test, ORs or case-control allele fre-
quency differences in a direction consistent with previous
reports) for SNPs at loci containing the genes ATXN2,
c12orf30, c3orf1, PTPN22, STAT4, and TRAF1-C5. Pos-
sible evidence of replication (defined as p < 0.2 for any
test, ORs or case-control allele frequency differences in a
direction consistent with previous reports) was also gener-
ated for SNPs near AFF3, CD226, MBL2, PSTPIP1, and
RANTES (CCL5). For IL15, we found a significant associ-
ation, but in the opposite direction to that previously
reported. The IL15 SNP is an A/T transversion with fre-
quencies of both alleles close to 50%, and thus there is the
possibility of allele reversal. Although our minor T allele
frequency in controls was entirely consistent with that
found in the prior study, it is difficult to be sure that the
IL15 assays used in both studies were based on the same
DNA strand. We therefore cannot be sure if our data sup-
ports replication. Additionally for CTLA4, considered a
general autoimmunity susceptibility gene but with con-
flicting association results for JIA [5,24], we did not gene-
rate any evidence of replication.
We then performed a sensitivity analysis in which we
included only cases (n = 200) and controls (n = 341) of
European ancestry using the stringent definition of self-
reported European ancestry of all four of the child’s
grandparents. Non-European participants, along with
participants for whom full grandparent data was not pro-
vided, were excluded. The outcome of this re-analysis is
shown in Additional file 1: Table S1 and Additional file 1:
Figure S1. In general, the results of this European-only
analysis were not materially different to the full sample
analysis (taking into account reduced statistical power
resulting from a reduction of sample size), with one
exception. ATXN2 appeared influenced by ethnicity,
with an opposite, non-significant, direction of effect
in the European subgroup.
In conclusion, we have provided independent replica-
tion data for JIA susceptibility loci that have previously
been identified using a generally limited number of
international sample collections. We have confirmed as-
sociation of JIA with SNPs close-by to c12orf30, c3orf1,
PTPN22, STAT4, and TRAF1-C5; and we have provided
further support for the association of SNPs close-by toAFF3, CD226, MBL2, PSTPIP1, and CCL5. A limitation
of our study was our relatively small sample size; our full
dataset had 80% power to detect an OR of 1.4 for an al-
lele at 20% frequency in the population at an alpha of
0.05. Given that many of the published ORs were less
than 1.4, and that a number of the SNPs analysed had
minor allele frequencies less than 20%, we cannot, from
our current data, exclude association of any of the SNPs
examined. Our current sample size also precluded de-
tailed subtype-specific association analyses. Large collab-
orative GWAS efforts would be beneficial in confirming
the outstanding genes, and providing further novel in-
sights into the breadth of genetic loci involved in JIA
susceptibility.
Additional file
Additional file 1: Data pertaining to SNPs removed from analysis
during QC, and re-analysis of SNP association restricted to those of
confirmed European descent.
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